Coloplast A/S (COLO B.CO) stock: key figures, P/E, revenue and dividend
Health Care · Denmark · ISIN DK0060448595
Coloplast A/S financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 27.03 bn DKK | 27.87 bn DKK |
| Gross profit | 18.27 bn DKK | 18.14 bn DKK |
| Operating income | 7.32 bn DKK | 7.58 bn DKK |
| Net income | 5.05 bn DKK | 3.64 bn DKK |
| Diluted EPS – continuing operations | 22.46 DKK | 16.13 DKK |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
More stocks
- Ageas SA (AGS.BR)
- Fair Isaac (FICO)
- Suncorp Group Ltd (SUN.AX)
- Lundin Gold Inc (LUG.TO)
- Coloplast A (CLPBY)
- Daiwa Securities Group Inc (8601.T)
- Coeur Mining, Inc. (CDE)
- Zhongjin Gold Corp Ltd (600489.SS)
- Rivian Automotive, Inc. / DE (RIVN)
- Hyatt Hotels Corp (H)
- JD Health International Inc (6618.HK)
- Furukawa Electric Co Ltd (5801.T)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.